These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 8683128

  • 1. Analysis of the site of interaction of CD28 with its counter-receptors CD80 and CD86 and correlation with function.
    Kariv I, Truneh A, Sweet RW.
    J Immunol; 1996 Jul 01; 157(1):29-38. PubMed ID: 8683128
    [Abstract] [Full Text] [Related]

  • 2. Interactions of CD80 and CD86 with CD28 and CTLA4.
    Ellis JH, Burden MN, Vinogradov DV, Linge C, Crowe JS.
    J Immunol; 1996 Apr 15; 156(8):2700-9. PubMed ID: 8609386
    [Abstract] [Full Text] [Related]

  • 3. Differential recognition by CD28 of its cognate counter receptors CD80 (B7.1) and B70 (B7.2): analysis by site directed mutagenesis.
    Truneh A, Reddy M, Ryan P, Lyn SD, Eichman C, Couez D, Hurle MR, Sekaly RP, Olive D, Sweet R.
    Mol Immunol; 1996 Feb 15; 33(3):321-34. PubMed ID: 8649453
    [Abstract] [Full Text] [Related]

  • 4. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
    van den Beucken T, van Neer N, Sablon E, Desmet J, Celis L, Hoogenboom HR, Hufton SE.
    J Mol Biol; 2001 Jul 13; 310(3):591-601. PubMed ID: 11439026
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of CTLA-4 substitutions on the binding of human CD80 (B7-1) and CD86 (B7-2).
    Morton PA, Fu XT, Stewart JA, Giacoletto KS, White SL, Leysath CE, Evans RJ, Shieh JJ, Karr RW.
    J Immunol; 1996 Feb 01; 156(3):1047-54. PubMed ID: 8557978
    [Abstract] [Full Text] [Related]

  • 6. A novel bispecific tetravalent antibody fusion protein to target costimulatory activity for T-cell activation to tumor cells overexpressing ErbB2/HER2.
    Biburger M, Weth R, Wels WS.
    J Mol Biol; 2005 Mar 11; 346(5):1299-311. PubMed ID: 15713482
    [Abstract] [Full Text] [Related]

  • 7. New polymorphisms of human CD80 and CD86: lack of association with rheumatoid arthritis and systemic lupus erythematosus.
    Matsushita M, Tsuchiya N, Oka T, Yamane A, Tokunaga K.
    Genes Immun; 2000 Oct 11; 1(7):428-34. PubMed ID: 11196673
    [Abstract] [Full Text] [Related]

  • 8. Induction of apoptosis in Herpesvirus saimiri-immortalized T lymphocytes by blocking interaction of CD28 with CD80/CD86.
    Akari H, Fukumori T, Iida S, Adachi A.
    Biochem Biophys Res Commun; 1999 Sep 24; 263(2):352-6. PubMed ID: 10491296
    [Abstract] [Full Text] [Related]

  • 9. Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1.
    Peach RJ, Bajorath J, Brady W, Leytze G, Greene J, Naemura J, Linsley PS.
    J Exp Med; 1994 Dec 01; 180(6):2049-58. PubMed ID: 7964482
    [Abstract] [Full Text] [Related]

  • 10. Insertion of host-derived costimulatory molecules CD80 (B7.1) and CD86 (B7.2) into human immunodeficiency virus type 1 affects the virus life cycle.
    Giguère JF, Bounou S, Paquette JS, Madrenas J, Tremblay MJ.
    J Virol; 2004 Jun 01; 78(12):6222-32. PubMed ID: 15163715
    [Abstract] [Full Text] [Related]

  • 11. Expression and purification of monospecific and bispecific recombinant antibody fragments derived from antibodies that block the CD80/CD86-CD28 costimulatory pathway.
    Dincq S, Bosman F, Buyse MA, Degrieck R, Celis L, de Boer M, Van Doorsselaere V, Sablon E.
    Protein Expr Purif; 2001 Jun 01; 22(1):11-24. PubMed ID: 11388794
    [Abstract] [Full Text] [Related]

  • 12. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K, Neena K, Chitralekha KT, Arif AK, Tomar D, Rao DN.
    Int Immunopharmacol; 2004 Jan 01; 4(1):1-14. PubMed ID: 14975355
    [Abstract] [Full Text] [Related]

  • 13. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y, Hiraoka S, Tomura M, Zhou XY, Yashiro-Ohtani Y, Mori Y, Shimizu J, Ono S, Dunussi-Joannopoulos K, Wolf S, Fujiwara H.
    Int Immunol; 2005 Jan 01; 17(1):73-83. PubMed ID: 15569772
    [Abstract] [Full Text] [Related]

  • 14. Immunoglobulin fold characteristics of B7-1 (CD80) and B7-2 (CD86).
    Bajorath J, Peach RJ, Linsley PS.
    Protein Sci; 1994 Nov 01; 3(11):2148-50. PubMed ID: 7535614
    [Abstract] [Full Text] [Related]

  • 15. CTLA4-CD80/CD86 interactions on primary mouse CD4+ T cells integrate signal-strength information to modulate activation with Concanavalin A.
    Mukherjee S, Ahmed A, Nandi D.
    J Leukoc Biol; 2005 Jul 01; 78(1):144-57. PubMed ID: 15788440
    [Abstract] [Full Text] [Related]

  • 16. Design and expression of soluble CTLA-4 variable domain as a scaffold for the display of functional polypeptides.
    Nuttall SD, Rousch MJ, Irving RA, Hufton SE, Hoogenboom HR, Hudson PJ.
    Proteins; 1999 Aug 01; 36(2):217-27. PubMed ID: 10398368
    [Abstract] [Full Text] [Related]

  • 17. Evidence for the involvement of T cell costimulation through the B-7/CD28 pathway in atherosclerotic plaques from apolipoprotein E knockout mice.
    Afek A, Harats D, Roth A, Keren G, George J.
    Exp Mol Pathol; 2004 Jun 01; 76(3):219-23. PubMed ID: 15126104
    [Abstract] [Full Text] [Related]

  • 18. Molecular cloning and comparative analysis of the rhesus macaque costimulatory molecules CD80 (B7-1) and CD86 (B7-2).
    Zhang D, Johnson RP.
    Cell Immunol; 1997 Apr 10; 177(1):9-17. PubMed ID: 9140091
    [Abstract] [Full Text] [Related]

  • 19. Inflammatory cytokines IFN-gamma plus TNF-alpha induce regulated expression of CD80 (B7-1) but not CD86 (B7-2) on murine fibroblasts.
    Pechhold K, Patterson NB, Craighead N, Lee KP, June CH, Harlan DM.
    J Immunol; 1997 May 15; 158(10):4921-9. PubMed ID: 9144510
    [Abstract] [Full Text] [Related]

  • 20. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells.
    Akiba H, Oshima H, Takeda K, Atsuta M, Nakano H, Nakajima A, Nohara C, Yagita H, Okumura K.
    J Immunol; 1999 Jun 15; 162(12):7058-66. PubMed ID: 10358148
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.